SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on October 16, 2012, reporting events occurring on October 11, 2012. The filing documents the results of the Company's Annual Meeting of Stockholders and a subsequent amendment to its Bylaws. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the source text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
- Bylaw Amendment: Stockholders approved an amendment to the Bylaws to increase the number of authorized directors to a range of no fewer than six (6) and no more than ten (10).
- Director Elections: Four Class 1 directors were elected to two-year terms: Gary T. Steele, Frederick Frank, Steven Goldby, and Stephen E. Halprin.
- Accounting Firm Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending May 26, 2013.
- Executive Compensation: Stockholders approved a non-binding advisory proposal regarding executive compensation.
Voting Results Summary
| Proposal | Votes For | Votes Against | Abstain / Withheld |
|---|---|---|---|
| Bylaw Amendment | 20,255,040 | 97,031 | 81,026 |
| Director Election (Gary T. Steele) | 20,006,095 | 427,002 (Withheld) | N/A |
| Director Election (Frederick Frank) | 19,995,971 | 437,126 (Withheld) | N/A |
| Director Election (Steven Goldby) | 20,111,551 | 321,546 (Withheld) | N/A |
| Director Election (Stephen E. Halprin) | 20,004,789 | 428,308 (Withheld) | N/A |
| Accounting Firm Ratification | 23,933,604 | 67,572 | 7,853 |
| Executive Compensation (Say-on-Pay) | 20,101,583 | 210,387 | 121,127 |
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, or contingencies. It is strictly a report of the voting outcomes and the effective date of the Bylaw amendment.
Key Facts for Investor Verification
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Confirm the new authorized director range is 6 to 10.
- Note the fiscal year end date is May 26, 2013.
- Review the attached Exhibit 3.1 for the full text of the Amended and Restated Bylaws.